Skip to main content
← All Sectors

SECTOR · UPDATED DAILY

Pharma Startups Recently Funded

46 Pharma companies on record, most common stage: Pre-Seed. $14M in total reported offering amounts. Sourced directly from SEC Form D filings, indexed within 24 hours of submission.

46
Companies indexed
$14M
Total reported offering amount
Pre-Seed
Top stage
--
Most recent filing

Recent filings

10 Most Recent Raises

CompanyAmountFiling dateStageLocation
ESSENTIA PHARMA SOCAL, LLC------Rosenberg, TX
BTG PLC$4M--Series BLondon, X0
IMC Corp------Mercedita, PR
Manzo Pharmaceuticals, Inc------Milford, PA
Altus RX, L.P.------Pearland, TX
NOMOCAN PHARMACEUTICALS LLC$740K--Pre-SeedBrooklyn, NY
Savara Inc.----GrowthAustin, TX
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)----Series BKnoxville, TN
Hapten Sciences, Inc.----Series AMemphis, TN
Renthera Corp------Austin, TX

Stage breakdown

Companies by Stage

Pre-Seed
8
Seed
5
Series A
4
Series B
2
Growth
2

Bar width proportional to company count. Covers companies with stage classifications in the FlareSight database.

Data source

How We Source This Data

Every company on this page corresponds to a verified SEC Form D filing in the FlareSight database. Form D is a federal disclosure document issuers must file within 15 days of a first sale under Regulation D. It captures the issuer name, offering amount, and sector classification.

FlareSight pulls new filings from SEC EDGAR within 24 hours of submission and classifies each company by sector based on the filing and enrichment data. No press scraping, no estimates. Only primary-source SEC records.

Because Form D is a disclosure rather than an audited record, total offering amounts may include amounts not yet sold. Amendments to earlier filings can update the dollar figure. For the most current picture, browse the startup funding database.

Browse all Pharma companies

Filter by filing date, stage, location, and amount. See founder contacts and enrichment data. Free tier, no credit card.

Search Pharmacompanies →